Axxonis Pharma AG, has identified and patented several new chemical entities as neuroprotective agents
Berlin (ots) - The new compounds will provide a "full time" protection of neurons against aging and degeneration. Continuous administration technologies, which are one of the core competencies of Axxonis Pharma AG, will additionally enable the concept of 24 hours protection. This is a completely new and innovative approach in radical scavenging therapy and in ...
mehr